Nurse Practitioner, Adult Health · New York, NY
NPI
1033434477
Since 2010
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
262 Central Park W, Suite 1d
New York, NY, 10024
Phone (212) 535-7546
Groups this clinician bills Medicare through
Medicare paid, 2024
$227K
18,115 services
Medicare patients, 2024
454
Average age 77
Drug cost, 2024
$244K
2,278 prescriptions
Company payments, 2025
$6,588
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Viktoriya Fridman was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 11,300 times for 65 patients. In total Viktoriya Fridman billed 18,115 services in 32 codes, and Medicare paid $227K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-11-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 11,300 | 65 | $1.29 | $15K |
| 17003 Destruction Skin Lesion | Office | 3,982 | 256 | $5.09 | $20K |
| 17000 Destruction Skin Lesion | Office | 632 | 281 | $32.95 | $21K |
| 99213 Office E&M - Established | Office | 617 | 299 | $67.21 | $41K |
| 17110 Destruction Skin Lesion | Office | 478 | 235 | $86.59 | $41K |
| 11102 Skin Biopsy | Office | 218 | 183 | $59.39 | $13K |
| 99214 Office E&M - Established | Office | 136 | 107 | $97.59 | $13K |
| 99203 Office E&M - New | Office | 121 | 121 | $81.35 | $9,844 |
| 17004 Destruction Skin Lesion | Office | 105 | 63 | $128.51 | $13K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 102 | 54 | $0.72 | $73.93 |
| 11900 Skin | Office | 83 | 49 | $27.10 | $2,250 |
| 96573 Skin | Office | 76 | 53 | $173.52 | $13K |
| 11103 Skin Biopsy | Office | 53 | 46 | $39.78 | $2,108 |
| 99212 Office E&M - Established | Office | 46 | 42 | $42.77 | $1,967 |
| 96574 Skin | Office | 37 | 29 | $214.90 | $7,951 |
By year: 2022 $779K for 11,585 services; 2023 $507K for 19,794 services; 2024 $227K for 18,115 services.
Medicare prescription drug claims, 2024
In 2024, the drug Viktoriya Fridman prescribed most often to Medicare patients was Ketoconazole, with 348 prescriptions and refills. In total Viktoriya Fridman wrote 2,278 Medicare prescriptions that cost $244K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 348 | 353 | 162 | $4,658 |
| Mupirocin Generic | 207 | 217 | 166 | $1,163 |
| Mometasone Furoate Generic | 169 | 171 | 134 | $2,935 |
| Clindamycin Phosphate Generic | 128 | 130 | 76 | $5,769 |
| Silver Sulfadiazine Generic | 121 | 138 | 99 | $1,822 |
| Clobetasol Propionate Generic | 110 | 115 | 71 | $9,885 |
| Nystatin Generic | 90 | 91 | 55 | $1,492 |
| Gentamicin Sulfate Generic | 66 | 66 | 49 | $2,463 |
| Calcipotriene Generic | 62 | 65 | 38 | $15K |
| Ammonium Lactate Generic | 59 | 59 | 45 | $753 |
| Econazole Nitrate Generic | 57 | 58 | 40 | $1,422 |
| Ssd Silver Sulfadiazine | 53 | 57 | 47 | $939 |
| Tacrolimus Generic | 50 | 53 | 36 | $6,756 |
| Metronidazole Generic | 44 | 45 | 27 | $1,992 |
| Halobetasol Propionate Generic | 36 | 36 | 25 | $2,907 |
Brand drugs: 392 claims; generic drugs: 1,886 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Viktoriya Fridman $6,588 ($6,588 in general payments such as food, travel and fees) from 20 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $2,330.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 16 | $2,330 |
| Incyte Corporation INCY | 22 | $979 |
| Abbvie Inc. ABBV | 9 | $517 |
| Genzyme Corporation SNY | 9 | $480 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 15 | $430 |
| Galderma Laboratories, L.P. GALD.SW | 4 | $354 |
| LEO Pharma Inc. | 5 | $333 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $243 |
| Amgen Inc. AMGN | 9 | $204 |
| Organon LLC OGN | 4 | $157 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.